NCT06473662View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

July 11, 2020

Study Completion Date

July 11, 2020

Conditions

Type 2 Diabetes Treated With Insulin

Interventions

DRUG

Oral insulin

Capsule administered by mouth with a glass of water two times per day, once before breakfast and once before supper

Trial Locations (1)

NW1 0NH

Diabetology, London

All Listed Sponsors

lead

Roger New

INDUSTRY

NCT06473662 - Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects | Biotech Hunter | Biotech Hunter